# The Sanatorium for cardiovascular disease Germanyer area # --- [](https://cardio-balance-ph.store-best.net) <div style="height:500px;"></div> ## Drugs against hypertension without side effects ## Kung nagsimula na ang pag-inom ng gamot para sa mataas na presyon, hindi ibig sabihin na hindi na maaaring gawin ang karagdagang mga hakbang para palakasin ang katawan sa programa ng therapy. Ang benepisyo ng maingat na mga hakbang na pinagkasunduan ng doktor ay nakakatulong para mapigilan ang paglala ng sakit at maiwasang lumipat ito sa mas seryosong yugto. Drugs against hypertension without side effects: A critical review High blood pressure, known medically as hypertension, is a global health problem and is considered to be one of the main risk factors for cardiovascular diseases such as heart attack and stroke. The pharmacotherapy of hypertension includes a variety of active groups, including ACE inhibitors, AT1 receptor blockers (Sartans), beta-blockers, calcium channel blockers, and diuretics. A recurring concern of patients and Physicians, the question of whether medication for high blood pressure exist, all of which are completely free of side effects, however. The dream of a side-effect-free therapy Dieusschließlich side-effect-free drugs in modern medicine practical. Any pharmacological substance interacts with biological systems, and can trigger unwanted effects. The designation without side effects is therefore always relative, and often refers to a favorable risk‑Benefit balance, the positive effects outweigh by far, and the side effects are mild, rare or well controlled. Drug groups and their side-effect profile ACE inhibitors (eg, Lisinopril, Ramipril): The main effect is the reduction of blood pressure by inhibiting the Angiotensin‑converting enzyme. Typical side effects: dry cough (approximately 5-10% of patients), Hyperkalemia, in rare cases, angioedema. AT1‑receptor blockers (Sartans, such as Losartan, Valsartan): Advantage: do not cause a cough, as they bypass the ACE demise. Side effects: rarely-Hyperkalemia, and renal dysfunction. Calcium channel blockers (e.g. amlodipine): Mechanism of action: the Relaxation of the blood vessels due to Blockade of calcium influx in smooth muscle cells. Potential side effects: Edema of the legs, headache, dizziness. Diuretics (Thiazides, e.g., hydrochlorothiazide): Effect: reduction of blood volume by increased excretion of water and salt. Known side effects: electrolyte disturbances (loss of Potassium), increased blood sugar levels, increased uric acid level. Beta-Blockers (Metoprolol, Bisoprolol): Application: particularly in patients with heart failure or after myocardial infarction. Limitations: possible fatigue, coldness of the limbs, slowing of the heartbeat. A complete avoidance of the side effects is that possible? A complete avoidance of side effects in the blood-pressure-lowering drugs is not currently realistic. The individual tolerance varies greatly: What is a patient in an intolerable side effect, the other will go unnoticed. Strategies to minimize side effects In order to reduce the risk and incidence of adverse reactions, the following procedure is recommended: Individual Therapy adjustments: selection of the active substance based on co-morbidities (e.g., Diabetes, kidney disease). Low dosage to start: Start with a low dose and gradually increased until optimum blood pressure control. Combination therapy: Low-dose combinations of different classes of drugs can increase the efficacy and the side effect rate is lower. Regular monitoring: Monitoring of blood pressure, electrolytes and renal function. Style changes: weight loss, reduction of salt intake, regular physical activity and avoiding Smoking and excessive alcohol consumption, life can reduce the dosage of medication or even superfluous. Conclusion Drugs that treat high blood pressure and without any side effects do not exist currently. Medical progress has, however, led to drugs that have a very favorable safety profile. The optimal therapy is the result of a combination of pharmacological options and non‑pharmacological measures under strict individual vote. The open dialogue between the doctor and the Patient, is of crucial importance to find the best treatment with the lowest risk of side effects. Cardio Balance is an all-natural formula designed to act on the root cause of high blood pressure and fatal cardiovascular diseases and strokes. It's a zero-risk range for men and women of all ages. The natural ingredients-rich nutrient profile helps reduce blood cholesterol levels and boost blood circulation function, digestive system, and overall health. > Ang mga tableta para pababain ang presyon ng dugo ay natural na nakakatulong para mabilis itong bumalik sa normal, pero inirerekomenda rin na baguhin ang pamumuhay. Ang malusog na pagkain, kontrol sa timbang, regular na ehersisyo, at pag-iwas sa paninigarilyo at alak ay magagandang paraan para maiwasan ang mataas na presyon ng dugo. Siguraduhing mas kaunting sodium (hal. asin) at mas maraming potassium (mga saging, spinach, broccoli) ang mapapasok sa katawan.  <a href="http://villacaprareccia.it/writable/public/userfiles/cardiovascular-disease-lecture.xml">PUMUNTA SA WEBSITE>>> </a> Kasabay nito, hindi inirerekomenda ang pangmatagalang pag-inom ng mga gamot mula sa kategoryang Diuretics, dahil ang mahahalagang sangkap tulad ng Potassium, Calcium, Magnesium ay mabilis na nailalabas sa katawan kasama ng sobrang tubig at asin. Alinsunod sa katangiang ito, sinasabayan ng mga Diuretics ang pag-inom ng mga gamot na may laman ng mga sangkap na ito. Maaaring ito ay mga vitamin at mineral na complexes, monokomponent, o mga suplemento sa pagkain na may napatunayang klinikal na bisa. <a href="http://videlec.be/ressource/cardiovascular-disease-information.xml">PUMUNTA SA WEBSITE>>> </a> The Sanatorium for cardiovascular disease in the Germanyer area: structure, therapeutic approaches, and effectiveness Sit of cardiovascular diseases represents one of the main causes of morbidity and mortality. In this context, rehabilitation facilities, in particular, sanatoriums, play an important role in improving the quality of life and prognosis of patients. The present paper investigates the structure and the therapeutic concepts of a typical clinic for cardiovascular diseases in the Germanyer area. Location and facilities The Sanatorium is located in a green Zone of the Germanyer area, usually in an area with favorable climatic conditions. The distance from the city enables a reduction of the environmental pollution (air pollution, noise), which is for patients with cardiovascular disorders is of great importance. The device has: a diagnostic Department with modern equipment to echocardiography, exercise ECG (treadmill or Bicycle Test), long‑term ECG and blood pressure monitoring; therapeutic rooms for physiotherapy, Massage and exercise therapy; a range of hydrotherapy (baths, showers); Rooms for psychological support and education of patients a way to healthy life; comfortable Accommodation and a dietary supply, tailored to the needs of cardiac patients (salt reduced cholesterol lowering). Indications for admission The main indications for a sanatorium stay are: stabilized Phase after myocardial infarction (according to a doctor's approval); stable Angina pectoris (class I–III according to CCS); arterial hypertension (in the stage of stabilization); Congestive heart failure NYHA stages I–II; postoperative Rehabilitation after cardiovascular surgery (coronary bypass, valve operations) under medical supervision; Prevention in high-risk for cardiovascular diseases (Metabolic syndrome, type 2 Diabetes mellitus with cardiovascular risk assessment). Therapeutic Measures The multi-modal approach that includes: Drug therapy: a continuation, and optimization of the prescribed medication (beta-blockers, ACE inhibitors, statins, anticoagulants). Movement therapy: graded and controlled physical activity, starting with walks and breathing exercises, followed by moderate Aerobic and strength training under Supervision. The climate therapy: application of electrotherapy, magnetic therapy, and targeted effect on the climate (climatic health, walks in the woods). Hydro-therapy: therapeutic mineral water pools, Kneipp treatments, for the improvement of vascular tone and blood circulation. Nutrition advice: training on a heart healthy diet (DASH diet, Mediterranean diet), individual and group discussions with nutritionists. Psychosomatic Support: Stress Management, Relaxation Techniques (Autogenic Training, Progressive Muscle Relaxation), Group Therapy. Patient education: Knowledge about the disease, medication compliance, self-monitoring (blood pressure, pulse) and signs of deterioration. Effectiveness and results Studies show that a sanatorium stay leads to the following positive effects: Reduction of symptoms (e.g., angina discomfort, dyspnea); Improvement of exercise capacity and cardiac output (as demonstrated by improved performance in the stress test); Normalization of blood pressure and lipid spectrum; Reducing body weight and waist circumference in obese patients; Improving mental stabilization and quality of life; Reduction in the Rate of rehospitalization cases in the following year. Conclusion Sanatoriums in the Germanyer area constitute an effective pillar of cardiac Rehabilitation. Through the combination of medical care, physical Rehabilitation, nutritional and behavioral counseling, and psychosocial support, you can improve the quality of life of the patients sustained and the risk of further cardiovascular events is lower. A close cooperation with outpatient and inpatient facilities is a prerequisite for a continuous and successful patient care. ## Cardio Balance best medicine against high blood pressure ## Of course! Here is a scientific Text is in German on the subject of Edarbi as an effective drug against high blood pressure: Edarbi: A modern approach to the therapy of arterial hypertension The arterial hypertension (high blood pressure) is a global health problem and is considered to be one of the main risk factors for cardiovascular disease, including heart attack, stroke, and congestive heart failure. The effective reduction in blood pressure is, therefore, of crucial importance for the prevention of these life-threatening complications. In this context, Edarbi (active ingredient: Azilsartan medoxomil) has established itself as a highly effective and safe drug for the long-term treatment of hypertension. Pharmacological Mechanism Of Action Edarbi belongs to the class of Angiotensin II receptor antagonists (AT1‑receptor blocker). The active ingredient Azilsartan medoxomil selectively inhibits the binding of Angiotensin II to its AT1 receptors, the vessels mainly in the blood, heart, and kidneys are located. Through this inhibition, the following effects can be achieved: Vasodilation (Vascular Dilation), Reduction in Aldosterone secretion, Decrease of peripheral vascular resistance, Lowering of blood pressure. In comparison to other AT1 receptor blocker Azilsartan shows a particularly strong and long-lasting binding to the receptors, which leads to a stable blood pressure control over 24 hours. Clinical Efficacy Several randomized controlled trials (RCTs) have demonstrated the efficacy of Edarbi in patients with mild-to-moderate hypertension. In a pivotal study, it was shown that a daily dose of 40 mg or 80 mg Azilsartan medoxomil leads to a significant reduction in both systolic and diastolic blood pressure, compared to Placebo and other antihypertensive drugs such as Valsartan or Olmesartan. Particularly, the effectiveness is emphasized in patients who do not respond to other AT1‑Blocker inadequate. Edarbi also shows in elderly patients and in patients with metabolic syndrome have a good efficacy and tolerability. Safety and tolerability In clinical studies, Edarbi showed a favorable safety profile. The most common side effects were: Headache, Dizziness, Fatigue, slight hypotension. However, these effects occur are usually mild and rarely lead to discontinuation of therapy. Compared to ACE inhibitors (e.g. Ramipril) gives Edarbi no irritating cough, which improves the long-term patient compliance significantly. Dosage and administration Diefangsdosis is 40 mg once a day. In case of insufficient reduction in blood pressure, the dose can be increased to 80 mg/day. Edarbi, regardless of the meals. In patients with moderate renal impairment no dose adjustment is required; in the case of severe kidney or liver disease, the therapy should be carried out with particular caution. Conclusion Edarbi (Azilsartan medoxomil), due to its high effectiveness, long-lasting effect and good tolerability is a valuable adjunct in the therapy of arterial hypertension. It is, in particular, patients who do not respond to other antihypertensives inadequate or side effects, offers an effective Alternative. An individual Benefit-risk assessment by the attending physician, however, is always required. If you want, I can customize the Text, cut or other aspects (e.g., direct comparisons with other drugs, long-term data, cost‑Benefit considerations), complement! <a href="http://shell-moh.eu/uploads/assets/3419-project-cardiovascular-diseases.xml">Drugs against hypertension without side effects</a> The Sanatorium for cardiovascular disease Germanyer area. <a href="http://namealogysupreme.com/userfiles/opportunities-for-the-prevention-of-cardiovascular-diseases-276.xml">Drugs against hypertension without side effects</a> <a href="http://www.sexymasseur.com/userfiles/3297-what-are-the-symptoms-of-cardiovascular-diseases.xml">Cardio Balance best medicine against high blood pressure</a> <a href="https://md.infs.ch/s/L-XDDoxSD_">The mortality due to hypertension</a> <a href="https://md.bytewerk.org/s/dRUuTTAp55">https://md.bytewerk.org/s/dRUuTTAp55</a> <a href="https://doc.interscalar.eu/s/12YqIWKSQ">https://doc.interscalar.eu/s/12YqIWKSQ</a> <a href="https://hedgedoc.stusta.de/s/ZdG4M3mdw">https://hedgedoc.stusta.de/s/ZdG4M3mdw</a> <a href="https://notes.rabjerg.de/s/BJWxnD9GMe">https://notes.rabjerg.de/s/BJWxnD9GMe</a> <a href="https://notes.llgoewer.de/s/AfCfRFms2">https://notes.llgoewer.de/s/AfCfRFms2</a> <a href="https://md.eris.cc/s/V3GQXoqaJZ">https://md.eris.cc/s/V3GQXoqaJZ</a> <a href="https://pads.cantorgymnasium.de/s/-S3UH0p0k">https://pads.cantorgymnasium.de/s/-S3UH0p0k</a> <a href="https://hedgedoc.faimaison.net/s/ylgPPCn-aJ">https://hedgedoc.faimaison.net/s/ylgPPCn-aJ</a> <a href="https://pad.stuve.de/s/Qdv_-bNkh">https://pad.stuve.de/s/Qdv_-bNkh</a> <a href="https://hedgedoc.private.coffee/s/Z50W0WdZm">https://hedgedoc.private.coffee/s/Z50W0WdZm</a> <a href="https://pads.tobast.fr/s/duYRmth1Ty">https://pads.tobast.fr/s/duYRmth1Ty</a> <a href="https://doc.interscalar.eu/s/tqxpaXUEA">https://doc.interscalar.eu/s/tqxpaXUEA</a> <a href="https://hd.wedler.me/s/2kaV8JphS">https://hd.wedler.me/s/2kaV8JphS</a> <a href="https://pad.c3voc.de/s/1NR9QUrw_">https://pad.c3voc.de/s/1NR9QUrw_</a> <a href="https://md.micronited.de/s/B1eG3D9zMe">https://md.micronited.de/s/B1eG3D9zMe</a> <a href="https://docs.snowdrift.coop/s/4cjecy1pm">https://docs.snowdrift.coop/s/4cjecy1pm</a> <a href="https://doc.hkispace.com/s/g7DVgzZx3">https://doc.hkispace.com/s/g7DVgzZx3</a> <a href="https://om-office.de/s/SkLG3v5MGl">https://om-office.de/s/SkLG3v5MGl</a> <a href="https://text.fraction.jp/s/c26OFT8ai">https://text.fraction.jp/s/c26OFT8ai</a> <a href="https://pad.stuve.de/s/XCZc1EzpC">https://pad.stuve.de/s/XCZc1EzpC</a> <a href="https://md.coredump.ch/s/lNELGg2Bx">https://md.coredump.ch/s/lNELGg2Bx</a> <a href="https://hedgedoc.timon.ch/s/hyGJjLLw8">https://hedgedoc.timon.ch/s/hyGJjLLw8</a> <a href="https://hedgedoc.stanleysolutionsnw.com/s/kqgFoBA05R">https://hedgedoc.stanleysolutionsnw.com/s/kqgFoBA05R</a> <a href="https://pad.mytga.de/s/j5d5mkDhB">https://pad.mytga.de/s/j5d5mkDhB</a> <a href="https://pad.mytga.de/s/lTOlK3YZ9">https://pad.mytga.de/s/lTOlK3YZ9</a> <a href="https://pad.eisfunke.com/s/6LEbNZ48i5">https://pad.eisfunke.com/s/6LEbNZ48i5</a> <a href="https://pad.wolkenbar.de/s/WcS0QtH0sw">https://pad.wolkenbar.de/s/WcS0QtH0sw</a> <a href="https://pad.hxx.cz/s/8Usqdj_46Y">https://pad.hxx.cz/s/8Usqdj_46Y</a> <a href="https://md.giplt.nl/s/7gx-rbWWUF">https://md.giplt.nl/s/7gx-rbWWUF</a> <a href="https://hedgedoc.digilol.net/s/bDvGrBbY_1">https://hedgedoc.digilol.net/s/bDvGrBbY_1</a> <a href="https://pad.medialepfade.net/s/mZgRl_R-w">https://pad.medialepfade.net/s/mZgRl_R-w</a> <a href="https://md.chaosdorf.de/s/RO74zgbTuB">https://md.chaosdorf.de/s/RO74zgbTuB</a> <a href="https://md.rappet.xyz/s/XFZADpCRyG">https://md.rappet.xyz/s/XFZADpCRyG</a> <a href="https://editor.celtoi.org/s/82RRI8O2Z">https://editor.celtoi.org/s/82RRI8O2Z</a> <a href="https://pad.yuka.dev/s/u-24epvYEV">https://pad.yuka.dev/s/u-24epvYEV</a> <a href="https://pad.sra.uni-hannover.de/s/LdKsOATSSA">https://pad.sra.uni-hannover.de/s/LdKsOATSSA</a> <a href="https://hackmd.openmole.org/s/yt4SOqMUs">https://hackmd.openmole.org/s/yt4SOqMUs</a> <a href="https://www.notizen.kita.bayern/s/10-R0ZOovn">https://www.notizen.kita.bayern/s/10-R0ZOovn</a> <a href="https://markdown.iv.cs.uni-bonn.de/s/XO3j3hz3w">https://markdown.iv.cs.uni-bonn.de/s/XO3j3hz3w</a> <a href="https://md.mandragot.org/s/D9klHvfpuz">https://md.mandragot.org/s/D9klHvfpuz</a> <a href="https://hedgedoc.ichmann.de/s/Rh9_U82Qe-">https://hedgedoc.ichmann.de/s/Rh9_U82Qe-</a> <a href="https://doc.neutrinet.be/s/M_gBxDmtBT">https://doc.neutrinet.be/s/M_gBxDmtBT</a> <a href="https://pad.deckenpfronn.info/s/I_pmUq8Cj">https://pad.deckenpfronn.info/s/I_pmUq8Cj</a> <a href="https://notes.ip2i.in2p3.fr/s/s2lUSiiWE">https://notes.ip2i.in2p3.fr/s/s2lUSiiWE</a> <a href="https://hedgedoc.c3d2.de/s/rzsh0FzkZI">https://hedgedoc.c3d2.de/s/rzsh0FzkZI</a> <a href="https://pad.gusted.xyz/s/JFxhziP7k">https://pad.gusted.xyz/s/JFxhziP7k</a> <a href="https://hdoc.csirt-tooling.org/s/Yh_wPD_9MK">https://hdoc.csirt-tooling.org/s/Yh_wPD_9MK</a> <a href="https://notes.simeonreusch.com/s/5ZM8c5ywL">https://notes.simeonreusch.com/s/5ZM8c5ywL</a> <a href="https://hedgedoc.auro.re/s/qDepfxqcql">https://hedgedoc.auro.re/s/qDepfxqcql</a> <a href="https://doc.fsr.saarland/s/cT9m-nCrLd">https://doc.fsr.saarland/s/cT9m-nCrLd</a> <a href="https://notas.laotra.red/s/1PNiGeg-hA">https://notas.laotra.red/s/1PNiGeg-hA</a> <a href="https://hackmd.hub.yt/s/kg6eX0xgg">https://hackmd.hub.yt/s/kg6eX0xgg</a> <a href="https://codimd.pirati.cz/s/DTshepCiz">https://codimd.pirati.cz/s/DTshepCiz</a> <a href="https://notes.medien.rwth-aachen.de/s/EqW48yAASL">https://notes.medien.rwth-aachen.de/s/EqW48yAASL</a> <a href="https://docs.localcharts.org/s/FqbJJm0MW">https://docs.localcharts.org/s/FqbJJm0MW</a> <a href="https://hedgedoc.stura-ilmenau.de/s/OXCHtoirDg">https://hedgedoc.stura-ilmenau.de/s/OXCHtoirDg</a> <a href="https://notes.phys-el.ru/s/u6m0osj43E">https://notes.phys-el.ru/s/u6m0osj43E</a> <a href="https://hedgedoc.ctf.mcgill.ca/s/D79KlJ-SB">https://hedgedoc.ctf.mcgill.ca/s/D79KlJ-SB</a> <a href="https://hedgedoc.eclair.ec-lyon.fr/s/n8xUJOiJ7">https://hedgedoc.eclair.ec-lyon.fr/s/n8xUJOiJ7</a> <a href="https://hedgedoc.private.coffee/s/OOeEswp0q">https://hedgedoc.private.coffee/s/OOeEswp0q</a> <a href="https://docs.aix.inrae.fr/s/b3qQNTuFI">https://docs.aix.inrae.fr/s/b3qQNTuFI</a> <a href="https://md.bytewerk.org/s/Ikk6WkJi-A">https://md.bytewerk.org/s/Ikk6WkJi-A</a> <a href="https://pad.n39.eu/s/Kdph6etaQg">https://pad.n39.eu/s/Kdph6etaQg</a> <a href="https://hedgedoc.jcg.re/s/XMeaHUPbTk">https://hedgedoc.jcg.re/s/XMeaHUPbTk</a> <a href="https://doc.gnuragist.es/s/gBCy4Ovh6N">https://doc.gnuragist.es/s/gBCy4Ovh6N</a> <a href="https://hedgedoc.et.aksw.org/s/g6c-En29R">https://hedgedoc.et.aksw.org/s/g6c-En29R</a> <a href="https://md.softwarefreedom.net/s/B-O-j_Y4w">https://md.softwarefreedom.net/s/B-O-j_Y4w</a> <a href="https://pad.flipdot.org/s/4RUfttZswl">https://pad.flipdot.org/s/4RUfttZswl</a> <a href="https://pad.fablab-siegen.de/s/y4TMk_QsEG">https://pad.fablab-siegen.de/s/y4TMk_QsEG</a> <a href="https://edit.leiden.digital/s/KVHoRF0dY5">https://edit.leiden.digital/s/KVHoRF0dY5</a> <a href="https://md.sebastians.dev/s/ZMzFG-DXn">https://md.sebastians.dev/s/ZMzFG-DXn</a> <a href="https://pad.sigflag.at/s/3y-8zngKO">https://pad.sigflag.at/s/3y-8zngKO</a> <a href="https://md.coredump.ch/s/zr3wj0GMs">https://md.coredump.ch/s/zr3wj0GMs</a> <a href="https://codi.sevenvm.de/s/0b7VZ2Dw7">https://codi.sevenvm.de/s/0b7VZ2Dw7</a> <a href="https://md.nolog.cz/s/YBQEXzdPP">https://md.nolog.cz/s/YBQEXzdPP</a> <a href="https://write.frame.gargantext.org/s/B1dH5PczMg">https://write.frame.gargantext.org/s/B1dH5PczMg</a> <a href="https://pad.cttue.de/s/vLi2-QIY0">https://pad.cttue.de/s/vLi2-QIY0</a> <a href="https://pad.multiplace.org/s/B1CqhD9GGl">https://pad.multiplace.org/s/B1CqhD9GGl</a> <a href="https://doc.fung.uy/s/Nh0bf7ze24">https://doc.fung.uy/s/Nh0bf7ze24</a> <a href="https://hedge.amosamos.net/s/AlRCQDL7fU">https://hedge.amosamos.net/s/AlRCQDL7fU</a> ## The mortality due to hypertension ## Of course! Here, The mortality rate is a scientific Text on the subject due to high blood pressure: The mortality rate due to hypertension: Epidemiological aspects and health policy challenges Hypertension medical arterial hypertension referred to, represents one of the most important health challenges of the 21st century. This century. As a chronic disease, often with nonspecific symptoms, it does not apply at the same time as the silent Killer (silent Monster), since many of those Affected know for a long time, your blood pressure rises above a healthy value. Epidemiology and the global spread of According to estimates by the world health organization (WHO), worldwide suffer approximately 1{,28 billion adults aged 30 to 79 years, and high blood pressure. In Europe, the disease is estimated to affect every third adult. The prevalence increases with age, significantly: In the case of persons over the age of 65, it is more than 60%. Mortality rates and complications The arterial hypertension is a major risk factor for cardiovascular disease, which, in turn, represent the leading cause of death worldwide. Annually, according to WHO data, about 10{,8 million deaths, directly or indirectly, to high blood pressure due — that's the equivalent of around 19% of all global deaths. Among the most common life-threatening complications: Heart Attack (Myocardial Infarction); Stroke (apoplexy, cerebral Isch a mie or H a morrhagie); Congestive heart failure; Renal failure (chronic kidney disease, CKD); Vessel peripheral arterial disease, pad) diseases (. Studies show that a permanently increased systolic blood pressure (≥140 mmHg) increases the risk for a stroke,the Double and for a heart attack to the 1 {, 6 Times. Regional differences and socio-economic factors Interestingly, countries with low and middle incomes higher mortality rates due to hypertension as an industrial Nations. This depends, among other things, with: inadequate prevention, lack of access to medical care, the lack of long-term therapy and insufficient education together. Also in Germany, the social class plays a role: people with a lower socio-economic Status are more likely to have uncontrolled high blood pressure, and a 30% higher mortality due to cardiovascular events. Prevention and treatment is the key to reduce the mortality An effective reduction of hypertension-related mortality requires a multi-way concept: Early identification: Regular blood pressure measurements from the 40. Years of age (or earlier if family history). Life style modifications: reduction of salt consumption (&lt;5 g/day), healthy diet (DASH‑Di a t), physical activity (150 minutes/week), weight reduction, avoiding Smoking and excessive alcohol consumption. Drug therapy: the use of antihypertensive agents (ACE inhibitors, Sartans, beta-blockers, diuretics) with persistent blood pressure ≥140/90 mmHg. Long-term control: Regular follow-up and adherence support. Conclusion The mortality due to hypertension remains a serious health Problem, which can, however, be systematic prevention and adequate treatment significantly reduced. More social attention, better education and improved access to medical care, particularly in disadvantaged groups of the population are essential. If you want, I can make certain sections in more detail or additional statistical data and sources to add!